Archive for July, 2006

Sleeping Pill May Help With Nerve Disorder - PakTribune.com

Sleeping Pill May Help With Nerve DisorderPakTribune.com, Pakistan - 55 minutes ago… But four of five patients with the disease showed some improvement within an hour after taking zolpidem, a sleeping pill whose brand name is Ambien, the …

Read full story

Comments

UK small caps open lower, with Isoft hit by accounting … - Life Style Extra

UK small caps open lower, with Isoft hit by accounting …Life Style Extra, UK - Jul 21, 2006… It will also provide additional resources for the development of new formulations of zolpidem for the rehabilitation of people with brain injury. …

Read full story

Comments

UK small caps move into positive territory at midday; bucking … - Life Style Extra

UK small caps move into positive territory at midday; bucking …Life Style Extra, UK - Jul 21, 2006… It will also provide additional resources for the development of new formulations of zolpidem for the rehabilitation of people with brain injury. ReGen raises 1.1 mln stg via placing to fund Colostrinin … Life Style Extraall 11 related

Read full story

Comments

UK smallcap opening - ReGen Therapeutics down on 1.11 mln stg … - Life Style Extra

UK smallcap opening - ReGen Therapeutics down on 1.11 mln stg …Life Style Extra, UK - Jul 21, 2006… It will also provide additional resources for the development of new formulations of zolpidem for the rehabilitation of people with brain injury. ReGen raises 1.1 mln stg via placing to fund Colostrinin … Life Style ExtraUK small caps close lower, reversing gains; wider market down Life Style Extraall 11 related

Read full story

Comments

ReGen raises Colostrinin roll-out funds - NutraIngredients.com

ReGen raises Colostrinin roll-out fundsNutraIngredients.com, France - 11 hours ago… will also be used to carry out further work on the development of its constituent peptides as pharmaceuticals, and for new formulations of its Zolpidem for the …

Read full story

Comments

UK small caps close lower, reversing gains; wider market down - Life Style Extra

UK small caps close lower, reversing gains; wider market downLife Style Extra, UK - 5 hours ago… It will also provide additional resources for the development of new formulations of zolpidem for the rehabilitation of people with brain injury. … UK smallcap opening - ReGen Therapeutics down on 1.11 mln stg … Life Style ExtraReGen raises 1.1 mln stg via placing to fund Colostrinin … Life Style Extraall 11 related

Read full story

Comments

ReGen Therapeutics Plc Announces Issue of Equity - PharmaLive.com (press release)

ReGen Therapeutics Plc Announces Issue of EquityPharmaLive.com (press release), PA - 8 hours ago… of its constituent peptides as potential pharmaceuticals as well as providing additional resources for the development of new formulations of zolpidem for the …

Read full story

Comments

ReGen raises 1.1 mln stg via placing to fund Colostrinin … - Life Style Extra

ReGen raises 1.1 mln stg via placing to fund Colostrinin …Life Style Extra, UK - 2 hours ago… to fund further work on the development of Colostrinin's constituent peptides as potential pharmaceuticals, and for the development of zolpidem, which ReGen is … UK smallcap opening - ReGen Therapeutics down on 1.11 mln stg … Life Style Extraall 4 related

Read full story

Comments

New Data Support Long-Term Use of AMBIEN CRTM (zolpidem tartrate … - Yahoo! News (press release)

New Data Support Long-Term Use of AMBIEN CRTM (zolpidem tartrate …Yahoo! News (press release) - Jul 12, 2006BRIDGEWATER, NJ, July 12 /PRNewswire-FirstCall/ — Sanofi-aventis (Paris Bourse: EURONEXT: SAN; and New York: NYSE: SNY) today announced results from a study …

Read full story

Comments

New Data Support Long-Term Use of AMBIEN CRTM (zolpidem tartrate … - PipelineReview.com (press release)

New Data Support Long-Term Use of AMBIEN CRTM (zolpidem tartrate …PipelineReview.com (press release), Spain - Jul 13, 2006BRIDGEWATER, NJ, USA | Jul 12 2006 | Sanofi-aventis (Paris Bourse: EURONEXT: SAN; and New York: NYSE: SNY) today announced results from a study that …

Read full story

Comments

· « Previous entries